| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Madrigal Pharmaceuticals, Inc. (MDGL) has 11 insiders with recent SEC Form 4 filings, including 108 buys and 22 sells. MDGL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 452.2K | $228.91M | - | |
| Dir | 199.7K | $101.07M | - | |
| Dir | 199.7K | $101.06M | - | |
| CEO | 150.1K | $75.97M | - | |
| Dir | 27.3K | $13.84M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2024 | Levy Richard S | Director | Sale+OE | 11,000 | $257.48 | $2,832,334.60 | -13.0% | +9.2% | +26.7% | |
| Dec 15, 2023 | Waltermire Robert E.48 | Senior VP, Chief Pharma Dev. | Sale+OE | 4,000 | $235.50 | $942,000.00 | -14.0% | +2.7% | +28.4% | |
| Dec 14, 2023 | Baker Bros. Advisors LP59 | Director | Buy | 101,792 | $221.20 | $22,516,576.85 | +0.4% | +17.1% | +30.7% | |
| Dec 13, 2023 | Waltermire Robert E.48 | Senior VP, Chief Pharma Dev. | Sale+OE | 3,800 | $222.82 | $846,700.00 | -13.4% | +15.5% | +33.1% | |
| Dec 12, 2023 | Baker Bros. Advisors LP59 | Director | Buy | 34,578 | $218.31 | $7,548,615.76 | +0.1% | +17.1% | +38.0% | |
| Dec 5, 2023 | Lynch Brian Joseph45 | SVP And General Counsel | Sale+OE | 2,800 | $221.89 | $621,294.00 | -5.7% | +4.9% | +35.5% | |
| Nov 30, 2023 | Lynch Brian Joseph45 | SVP And General Counsel | Sale+OE | 7,000 | $201.50 | $1,410,480.00 | -8.0% | +25.1% | +61.4% | |
| Nov 21, 2023 | Baker Bros. Advisors LP59 | Director | Buy | 64,350 | $188.47 | $12,128,340.27 | +0.4% | +21.9% | +68.3% | |
| Nov 20, 2023 | Baker Bros. Advisors LP59 | Director | Buy | 67,079 | $178.11 | $11,947,279.55 | +0.3% | +20.9% | +65.3% | |
| Nov 15, 2023 | Baker Bros. Advisors LP59 | Director | Buy | 49,387 | $158.13 | $7,809,558.62 | +1.5% | +26.7% | +87.2% |